Endometrial cancer - factors affecting disease recurrence
Not yet recruiting
- Conditions
- Malignant neoplasm of endometrium,
- Registration Number
- CTRI/2021/04/032663
- Lead Sponsor
- Amrita Institute
- Brief Summary
This is an analysis of factors affecting recurrence in patients with endometrial cancer. Once the study is completed we will be providing a summary of the findings and publication details
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 300
Inclusion Criteria
Patients with carcinoma endometrium.
Exclusion Criteria
Uterine sarcoma.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival at 5 years Time of last follow up
- Secondary Outcome Measures
Name Time Method Recurrence free survival Date of recurrence
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular biomarkers are associated with endometrial cancer recurrence according to CTRI/2021/04/032663?
How do clinicopathologic factors in CTRI/2021/04/032663 compare to standard-of-care recurrence predictors for endometrial carcinoma?
What adverse event management strategies are relevant for endometrial cancer recurrence analysis in observational studies?
Are there specific genetic mutations or protein expressions linked to endometrial cancer recurrence in Amrita Institute's CTRI/2021/04/032663 study?
How might findings from CTRI/2021/04/032663 influence patient selection for endometrial cancer therapies targeting molecular subtypes?
Trial Locations
- Locations (1)
Amrita Institute of Medical Sciences
🇮🇳Ernakulam, KERALA, India
Amrita Institute of Medical Sciences🇮🇳Ernakulam, KERALA, IndiaAnupama RPrincipal investigator8891728600anupamarajanbabu@gmail.com